Combination Tonsillectomy and Hypoglossal Nerve Stimulation for OSA Patients With Lateral Pharyngeal Collapse
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT07724938
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Obstructive Sleep Apnea
- Sleep Disordered Breathing
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tonsillectomy — PROCEDURETonsillectomy
- HGNS — DEVICEHGNS alone (without concomitant tonsillectomy)
Study Details
The goal of this clinical trial is to learn whether removing the tonsils at the time of hypoglossal nerve stimulation improves treatment of obstructive sleep apnea in adults whose airway collapses from the side of the upper airway during sleep. The main questions it aims to answer are: 1. Does hypoglossal nerve stimulation combined with tonsillectomy reduce the severity of obstructive sleep apnea more than hypoglossal nerve stimulation alone? 2. Does tonsillectomy improve how effectively hypoglossal nerve stimulation opens and stabilizes the upper airway? Researchers will compare participants who receive hypoglossal nerve stimulation with tonsillectomy to participants who receive hypoglossal nerve stimulation alone. Participants will: * Complete sleep studies, questionnaires, and other assessments before and after treatment * Be randomly assigned to receive hypoglossal nerve stimulation either with or without tonsillectomy * Return for follow-up visits and sleep testing to evaluate treatment effectiveness * In a subset of participants, complete additional overnight testing to measure how treatment changes upper-airway collapsibility
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Aug 31, 2030
- Completion
- Feb 28, 2031
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: HGNS plus tonsillectomyHGNS plus concomitant tonsillectomy
- Active Comparator: HGNSHGNS alone (without concomitant tonsillectomy)
Primary Outcome Measure
Percent reduction in apnea-hypopnea index (AHI) [ Time Frame: 1 month of optimized therapy. ]
Central Contacts
- Daniel Vena, PhD16178520719
- Dillon Gilbertson, BASc617-732-6488
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | - |
Find similar trials in Boston, MA
Related Studies
- Pharmacological Activation of HMN for OSA Aim 2PHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- LinguaFlex Tongue Retractor (LTR) for the Treatment of OSA and Snoring in AdultsEnrolling By Invitation · Linguaflex, Inc. · Brighton, Massachusetts
- Prevalence and Impact of Obstructive Sleep Apnea in Multiple SclerosisRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Rescue Pharmacotherapy for OSAPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts